Also trades as: VVY.AS (AMS) · $vol 0M
0R3M.L LSE
Vivoryon Therapeutics N.V.
1W: +0.0%
1M: -2.7%
3M: -7.6%
YTD: -23.8%
1Y: -24.3%
3Y: -90.9%
€1.10 ($1.24)
+0.02 (+1.84%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$11M
-63.4% ▼
5Y CAGR: -24.5%
Total Liabilities
$3M
-25.1% ▼
5Y CAGR: +1.3%
Shareholders Equity
$8M
-70.0% ▼
5Y CAGR: -28.7%
Cash & Investments
$9M
-67.2% ▼
5Y CAGR: -25.8%
Total Debt
$102K
+168.4% ▲
5Y CAGR: -24.1%
Net Debt
-$9M
+50.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $26M | $15M | $27M | $19M | $9M |
| Short-Term Investments | $0 | $0 | $0 | $10M | $0 |
| Cash & ST Investments | $26M | $15M | $27M | $29M | $9M |
| Net Receivables | $129K | $3M | $4M | $495K | $312K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $21K | $2M | $7K | $512K | $390K |
| Total Current Assets | $29M | $20M | $31M | $30M | $10M |
| Property, Plant & Equip. | $390K | $285K | $176K | $76K | $124K |
| Goodwill & Intangibles | $565K | $533K | $494K | $941K | $865K |
| Long-Term Investments | $3K | $3M | $14K | $0 | $0 |
| Other Non-Current Assets | -$955 | -$818 | -$670 | $0 | $228K |
| Total Non-Current Assets | $958K | $4M | $684K | $1M | $1M |
| Total Assets | $30M | $25M | $31M | $31M | $11M |
| — Liabilities — | |||||
| Accounts Payable | $911K | $4M | $3M | $3M | $1M |
| Short-Term Debt | $90K | $92K | $94K | $38K | $60K |
| Deferred Revenue | -$911 | -$4K | -$3K | $0 | $0 |
| Other Current Liabilities | -$21K | $278K | $290K | -$27K | $264K |
| Total Current Liabilities | $1M | $5M | $3M | $3M | $1M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $2M | $2M | $1M | $1M | $2M |
| Total Non-Current Liabilities | $2M | $3M | $2M | $1M | $2M |
| Total Liabilities | $4M | $8M | $5M | $5M | $3M |
| — Equity — | |||||
| Common Stock | $20M | $20M | $24M | $26M | $261K |
| Retained Earnings | -$80M | -$92M | -$120M | -$149M | -$169M |
| Accumulated OCI | -$655K | $6M | -$180K | $13M | -$268K |
| Total Stockholders Equity | $26M | $17M | $27M | $26M | $8M |
| Total Liabilities & Equity | $30M | $25M | $31M | $31M | $11M |
| — Key Metrics — | |||||
| Total Debt | $314K | $224K | $132K | $38K | $102K |
| Net Debt | -$26M | -$14M | -$26M | -$19M | -$9M |
| Total Investments | $3K | $3M | $14K | $10M | $0 |